GSK plc.
History
| Year | Detail |
|---|---|
| 1715 | Apothecary Silvanus Bevan opened Plough Court Pharmacy in 1715. |
| 1830 | The Smith & Gilbert drug house opened in Philadelphia, USA. |
| 1856 | The Plough Court pharmacy became Allen & Hanburys. Eventually, Glaxo Laboratories Ltd., one of GSK’s major legacy companies, acquired the company. |
| 1873 | Joseph Nathan, a Londoner, established the general trading company Joseph Nathan & Co. in New Zealand. Later, it was bought out by its subsidiary Glaxo Laboratories Ltd. in 1947. |
| 1880 | American pharmacists Henry S. Wellcome and Silas M. Burroughs founded Burroughs Wellcome & Co. in London. |
| 1921 | Insulin was discovered to manage diabetes, and Burroughs Wellcome and Allen & Hanburys were among the first to reproduce the hormone for commercial use in the U.K. |
| 1935 | In 1935, a subsidiary company, Glaxo Laboratories Ltd, was established. |
| 1947 | Glaxo had surpassed its parent in sales and product range and bought out Joseph Nathan & Co. |
| 1969 | Glaxo Laboratories Ltd. acquired Allen & Hanburys Ltd., a new R&D team that led to the introduction of the first asthma medicine. |
| 1984 | Marty St. Clair discovered an effective treatment for HIV, and it was made available to patients in early 1987. |
| 1989 | SmithKline Beckman Corp. merged with Beecham Group plc to form SmithKline Beecham plc. |
| 2000 | It was announced that Glaxo Wellcome plc was to merge with SmithKline Beecham plc to form GlaxoSmithKline plc. |
| 2009 | The company's partnership with Pfizer led to the launch of ViiV Healthcare. |
| 2014 | The company submitted a file for the world’s first malaria candidate vaccine to the European Medicines Agency. |
| 2018 | WHO piloted the vaccine launched by the company in Ghana, Kenya, and Malawi. |
| 2019 | The company acquired Tesaro, an oncology-focused biopharmaceutical company. |
| 2022 | GSK was reborn in 2022 as a company focused solely on developing new medicines and vaccines. |
| 2024 | GSK has acquired Aiolos Bio, a clinical-stage biopharmaceutical company focused on addressing the unmet treatment needs of patients with respiratory and inflammatory conditions. |
BCC Research Beacon 